Contract

Provision of full diagnostic histopathology service

  • Somerset NHS Foundation Trust

F03: Contract award notice

Notice identifier: 2025/S 000-015690

Procurement identifier (OCID): ocds-h6vhtk-050461 (view related notices)

Published 16 April 2025, 4:59pm



Section one: Contracting authority

one.1) Name and addresses

Somerset NHS Foundation Trust

Musgrove Park Hospital

Taunton

TA1 5DA

Contact

Hollie Caddy

Email

servicesteam.procurement@somersetft.nhs.uk

Country

United Kingdom

Region code

UKK23 - Somerset

Internet address(es)

Main address

https://www.somersetft.nhs.uk/

Buyer's address

https://www.somersetft.nhs.uk/

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Provision of full diagnostic histopathology service

two.1.2) Main CPV code

  • 85111800 - Pathology services

two.1.3) Type of contract

Services

two.1.4) Short description

Provision of full diagnostic histopathology service including Her2 Testing, Placenta (wet to report) and SP142/22C3 to support the Trusts Cancer Pathways.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £102,047

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKK23 - Somerset

two.2.4) Description of the procurement

This is a direct award to the incumbent supplier, Poundbury Cancer Institute, under the Provider Selection Regime (PSR) using Process C. This is an existing service.

The contract is for the provision of a diagnostic histopathology service.

The contract term is for one year, from 01/05/2025 to 30/04/2026.

The estimated value is £102,047.00.

two.2.5) Award criteria

Cost criterion - Name: Existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard / Weighting: 100

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The procurement falls outside the scope of application of the regulations

Explanation:

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 30 April 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

11 April 2025

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

POUNDBURY CANCER CENTRE LTD

Newborough House 3 Queen Mother Square

Poundbury

DT1 3BJ

Country

United Kingdom

NUTS code
  • UK - United Kingdom
The contractor is an SME

Yes

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £102,047

Total value of the contract/lot: £102,047


Section six. Complementary information

six.3) Additional information

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

The decision makers were: Service Manager Pathology & End of Life Services

No conflicts of interest were declared among decision makers.

The key criteria were weighted as follows:
50% quality and Innovation
10% Value
15% Integration, Collaboration and Service Sustainability
15% Improving access, reducing health inequalities and facilitating choice
10% Social value

The highest weighting has been applied to quality and innovation as the key objective is maintaining a high-quality service. The other elements of a quality led service have been weighted at 40%. Value in terms of cost has been weighted 10% because maintaining the quality of the service is the main objective of this award.

The rationale for choosing the provider with reference to the key criteria:
The existing suppliers are experienced services providers with a proven track record, and they are highly likely to be able to satisfy the new contract to a sufficient standard.

six.4) Procedures for review

six.4.1) Review body

Somerset NHS Foundation Trust

Musgrove Park Hospital

Taunton

TA1 5DA

Country

United Kingdom

Internet address

https://www.somersetft.nhs.uk/

six.4.2) Body responsible for mediation procedures

NHS England

7-8 Wellington Place

Leeds

LS1 4AP

Country

United Kingdom

Internet address

https://www.england.nhs.uk/